CTOR
Citius Oncology·NASDAQ
--
--(--)
--
--(--)
CTOR fundamentals
Citius Oncology (CTOR) released its earnings on Aug 12, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -0.08 (YoY -14.29%), missed estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.08
-14.29%
Report date
Aug 12, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Citius Oncology (CTOR) key financial stats and ratios, covering profitability, financial health, and leverage.
Citius Oncology (CTOR)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Citius Oncology (CTOR)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Citius Oncology (CTOR)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Citius Oncology (CTOR) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Citius Oncology (CTOR) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Citius Oncology's management provide for the next earnings period?What is Citius Oncology's gross profit margin?What is Citius Oncology's latest dividend and current dividend yield?What factors drove the changes in Citius Oncology's revenue and profit?What were the key takeaways from Citius Oncology’s earnings call?What is the revenue and EPS growth rate for Citius Oncology year over year?Did Citius Oncology beat or miss consensus estimates last quarter?What were the key takeaways from Citius Oncology's earnings call?
